BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29

• Press Releases

  X4 Pharmaceuticals Announces $60 Million Equity Financing with Concurrent Changes in Management and Board Leadership

  August 12, 2025

   · 

  8 min read
• Press Releases

  AAVantgarde Bio Announces FDA Fast Track Designation for AAVB-039 for the Treatment of Stargardt Disease

  August 12, 2025

   · 

  2 min read
• Press Releases

  Altimmune Announces Second Quarter 2025 Financial Results and Business Update

  August 12, 2025

   · 

  12 min read
• Press Releases

  Gain Therapeutics Reports Financial Results for Second Quarter 2025 and Provides Corporate Update

  August 12, 2025

   · 

  12 min read
• Press Releases

  Acumen Pharmaceuticals Reports Second Quarter 2025 Financial Results and Business Highlights

  August 12, 2025

   · 

  13 min read
• Press Releases

  Korro Reports Second Quarter 2025 Financial Results and Provides Business Updates

  August 12, 2025

   · 

  12 min read
• Press Releases

  Adverum Biotechnologies Reports Second Quarter 2025 Financial Results and Provides Pipeline Highlights

  August 12, 2025

   · 

  10 min read
• Press Releases

  Ocular Therapeutix™ Receives FDA Agreement Under Special Protocol Assessment (SPA) for Registrational Trial of AXPAXLI™ in NPDR

  August 12, 2025

   · 

  9 min read
• Press Releases

  Climb Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates

  August 12, 2025

   · 

  12 min read
• Press Releases

  Endure Biotherapeutics Receives SBIR Phase I Grant to Advance Engineered Native Bacteria Therapy for Familial Adenomatous Polyposis

  August 12, 2025

   · 

  2 min read